Laboratorios Farmaceuticos Rovi
ROVI.MC
#3310
Rank
S$4.78 B
Marketcap
$93.46
Share price
1.30%
Change (1 day)
1.82%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2024 (TTM): S$0.30 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are S$0.87 Billion. In 2023 the company made an earning of S$0.32 Billion a decrease over its 2022 earnings that were of S$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.30 B-4.99%
2023 S$0.32 B-12.68%
2022 S$0.37 B29.26%
2021 S$0.28 B149.39%
2020 S$0.11 B79.65%
2019 S$64.23 M128.8%
2018 S$28.07 M0.15%
2017 S$28.03 M-35.28%
2016 S$43.31 M27.59%
2015 S$33.95 M-32.06%
2014 S$49.97 M8.39%
2013 S$46.1 M-4.32%
2012 S$48.18 M2.78%
2011 S$46.88 M-2.15%
2010 S$47.91 M